PERCEPTIVE ADVISORS LLC 13D and 13G filings for Verona Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Verona Pharma plc VRNA |
PERCEPTIVE ADVISORS LLC | 6,565,933 8.100% |
1,447,788 (+28.29%) |
Filing |
| 2024-07-29 9:43 pm Purchase |
2024-07-17 | 13G | Verona Pharma plc VRNA |
PERCEPTIVE ADVISORS LLC | 5,118,145 6.300% |
1,251,931 (+32.38%) |
Filing |
| 2024-02-14 4:27 pm Sale |
2023-12-31 | 13G | Verona Pharma plc VRNA |
PERCEPTIVE ADVISORS LLC | 3,866,214 4.800% |
-596,452 (-13.37%) |
Filing |
| 2023-04-20 5:01 pm Purchase |
2023-04-18 | 13G | Verona Pharma plc VRNA |
PERCEPTIVE ADVISORS LLC | 4,462,666 5.600% |
4,462,666 (New Position) |
Filing |